Acknowledgements

Acknowledgements Cancer Immunology, Immunotherapy (2018) 67:507–511 https://doi.org/10.1007/s00262-018-2122-3 ACKNO WLEDGEMENT TO   RE VIE WERS © Springer-Verlag GmbH Germany, part of Springer Nature 2018 The Editors-in-Chief thank the following ad hoc reviewers and our Editorial Board for evaluating manuscripts submitted to Cancer Immunology, Immunotherapy in 2017. We are committed to the publication of research that advances the field of tumor immunology and immunotherapy and rely on our many reviewers to ensure that papers accepted by the journal adhere to all aspects of good scientific and ethical practice and have significant scientific merit. We very much appreciate the voluntary unremunerated provision of their expertise and time by our reviewers, and recognize that their constructive comments and recommendations are essential contributions promoting the overall quality of Cancer Immunology, Immu- notherapy and the scientific record. Aarntzen, Erik Azuma, Miyuki Bordron, Anne Abken, Hinrich Bosch, Jacobus Abrams, Scott Baba, Hideo Bosch-Voskens, Caroline Adema, Gosse Baban, Babak Brandau, Sven Adler, Frederick Bagarazzi, Mark Breckpot, Karine Adotevi, Olivier Bagley, Stephen Breitbach, Caroline Adusumilli, Prasad Bajor, David Briançon-Marjollet, Anne Aerts, Joachim Balachandran, Vinod Bright, Robert Akasaki, Yasuharu Baldanzi, Gianluca Brossart, Peter Alain, Tommy Ball, Edward Brownell, Isaac Albelda, Steven Banham, Alison Brudvik, Kristoffer Alici, Evren Barbuto, Jose Alexandre http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Immunology, Immunotherapy Springer Journals

Acknowledgements

Loading next page...
 
/lp/springer_journal/acknowledgements-cc4sqqJAHG
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer-Verlag GmbH Germany, part of Springer Nature
Subject
Medicine & Public Health; Oncology; Immunology; Cancer Research
ISSN
0340-7004
eISSN
1432-0851
D.O.I.
10.1007/s00262-018-2122-3
Publisher site
See Article on Publisher Site

Abstract

Cancer Immunology, Immunotherapy (2018) 67:507–511 https://doi.org/10.1007/s00262-018-2122-3 ACKNO WLEDGEMENT TO   RE VIE WERS © Springer-Verlag GmbH Germany, part of Springer Nature 2018 The Editors-in-Chief thank the following ad hoc reviewers and our Editorial Board for evaluating manuscripts submitted to Cancer Immunology, Immunotherapy in 2017. We are committed to the publication of research that advances the field of tumor immunology and immunotherapy and rely on our many reviewers to ensure that papers accepted by the journal adhere to all aspects of good scientific and ethical practice and have significant scientific merit. We very much appreciate the voluntary unremunerated provision of their expertise and time by our reviewers, and recognize that their constructive comments and recommendations are essential contributions promoting the overall quality of Cancer Immunology, Immu- notherapy and the scientific record. Aarntzen, Erik Azuma, Miyuki Bordron, Anne Abken, Hinrich Bosch, Jacobus Abrams, Scott Baba, Hideo Bosch-Voskens, Caroline Adema, Gosse Baban, Babak Brandau, Sven Adler, Frederick Bagarazzi, Mark Breckpot, Karine Adotevi, Olivier Bagley, Stephen Breitbach, Caroline Adusumilli, Prasad Bajor, David Briançon-Marjollet, Anne Aerts, Joachim Balachandran, Vinod Bright, Robert Akasaki, Yasuharu Baldanzi, Gianluca Brossart, Peter Alain, Tommy Ball, Edward Brownell, Isaac Albelda, Steven Banham, Alison Brudvik, Kristoffer Alici, Evren Barbuto, Jose Alexandre

Journal

Cancer Immunology, ImmunotherapySpringer Journals

Published: Feb 7, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off